Homology Medicines (STU:35H) Total Liabilities : €10.61 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Homology Medicines Total Liabilities?

Homology Medicines's Total Liabilities for the quarter that ended in Dec. 2023 was €10.61 Mil.

Homology Medicines's quarterly Total Liabilities increased from Jun. 2023 (€46.12 Mil) to Sep. 2023 (€48.59 Mil) but then declined from Sep. 2023 (€48.59 Mil) to Dec. 2023 (€10.61 Mil).

Homology Medicines's annual Total Liabilities increased from Dec. 2021 (€37.23 Mil) to Dec. 2022 (€47.66 Mil) but then declined from Dec. 2022 (€47.66 Mil) to Dec. 2023 (€10.61 Mil).

Homology Medicines Total Liabilities Historical Data

The historical data trend for Homology Medicines's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Homology Medicines Total Liabilities Chart

Homology Medicines Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

46.85

55.68

37.23

47.66

10.61

Homology Medicines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															47.66	42.95	46.12	48.59	10.61

Homology Medicines Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Homology Medicines's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.612	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10.61

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	77.545	-	66.933
	=	10.61

Homology Medicines's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.612	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10.61

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	77.545	-	66.933
	=	10.61

Homology Medicines Total Liabilities Related Terms

Thank you for viewing the detailed overview of Homology Medicines's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Homology Medicines (STU:35H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Homology Medicines Inc (STU:35H) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

FIXX:USA

Address

One Patriots Park, Bedford, MA, USA, 01730

Website

https://www.homologymedicines.com

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Homology Medicines (STU:35H) Headlines

No Headlines